ArticleCureus2026
Comparison of Functional Recovery and In-Hospital Outcomes Between Thrombolysed and Non-thrombolysed Patients With Acute Ischemic Stroke: A Retrospective Comparative Cohort Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Acute ischemic stroke is a major cause of mortality and long-term disability worldwide, contributing substantially to healthcare costs and socioeconomic burden, particularly in low- and middle-income countries. Timely restoration of cerebral perfusion remains the cornerstone of acute stroke management and is associated with improved neurological recovery and functional outcomes. Objective This study's objective is to compare functional recovery, in-hospital mortality, complications, and duration of hospitalization between thrombolysed and non-thrombolysed patients with acute ischemic stroke. Methods This retrospective comparative cohort study was conducted at Shalamar Hospital, Lahore, Pakistan, from December 2022 to December 2025 and included 157 patients diagnosed with acute ischemic stroke. All eligible patients meeting the inclusion criteria during the study period were included through non-probability consecutive sampling. Patients were categorized into thrombolysed (n = 62) and non-thrombolysed (n = 95) groups. Baseline stroke severity was assessed using the National Institutes of Health Stroke Scale (NIHSS), and functional outcomes were evaluated with the Modified Rankin Scale (mRS). The primary outcome was functional status at discharge. Results Thrombolysed patients had higher baseline NIHSS scores (13.2 ± 4.1 vs. 11.5 ± 3.8, p = 0.011). Despite greater initial severity, a higher proportion achieved favorable functional outcomes (mRS 0-2) compared to non-thrombolysed patients (37 (59.7%) vs. 38 (40.0%) (p = 0.014)). In-hospital mortality was lower in the thrombolysed group (six (9.7%) vs. 18 (18.9%) (p = 0.048)). Symptomatic intracranial hemorrhage occurred more frequently among thrombolysed patients (five (8.1%) vs. two (2.1%) (p = 0.041)). Mean hospital stay was shorter in the thrombolysed group (6.8 ± 2.9 days vs. 8.4 ± 3.7 days, p = 0.003). Conclusion Intravenous thrombolysis was associated with improved functional recovery, lower in-hospital mortality, and shorter hospitalization compared with conservative management. Although thrombolysis was associated with a higher frequency of symptomatic intracranial hemorrhage, the overall findings suggest a favorable benefit-risk profile in appropriately selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.